Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    15637262 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Condition: Non GIST Sarcomas
Intervention: Drug: sunitinib
2 Completed Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
Condition: Breast Cancer
Interventions: Behavioral: Exercise Training;   Behavioral: Chemo only
3 Unknown  Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth
Conditions: Colorectal Neoplasms;   Liver Neoplasms
Interventions: Procedure: immediate surgery (resection of primary colorectal tumor);   Drug: neo-adjuvant treatment with bevacizumab;   Drug: neoadjuvant treatment with capecitabine and oxaliplatin;   Drug: neo-adjuvant treatment with bevacizumab, capecitabine and oxaliplatin

Indicates status has not been verified in more than two years